eP259: A phase 1/2 trial of AXO-AAV-GM1 gene therapy for the treatment of infantile- and juvenile-onset GM1 gangliosidosis

0303 health sciences 03 medical and health sciences
DOI: 10.1016/j.gim.2022.01.294 Publication Date: 2022-03-21T09:30:37Z